As shown in Figure 2A, the DEGs were significant enriched in cancer associated pathways including surfactant metabolism, signaling by receptor tyrosine kinases, signaling by PDGF, non-integrin membrane-ECM interactions, MET activates PTK2 signaling, and so on. The gene discussed is PTK2; the disease is cancer.